TMX group

- Strong quarterly growth in gross profit margin following integration of
recent acquisitions -

MARKHAM, ON, Nov. 22 /CNW/ - Nightingale Informatix Corporation
("Nightingale" or the "Company") (TSX-V: NGH) one of North America's fastest
growing healthcare application service providers (ASP) of Electronic Medical
Record (EMR) and practice management solutions, announces its financial
results for the three and six month periods ended September 30, 2006.

<<
Q2 Fiscal 2007 Highlights
  -  Revenue of $3.5 million, a 17% increase over Q1 2007 and a 199%
     increase over Q2 2006
  -  Gross profit margin was 72%, up from 58% in Q1 2007, and down from
     91% in Q2 2006
  -  Net loss of $1.1 million compared to a net loss of $2.3 million in
     Q1 2007 and a net loss of $0.28 million in Q2 2006
  -  Completed the integration of HealtheNet and IHPS
  -  Grew pipeline of U.S.-based opportunities
>>

"We are pleased with our financial performance in the quarter, which was
driven by a combination of organic growth and acquisition activity," said Sam
Chebib, President and CEO of Nightingale. "During the quarter, we continued to
invest in our business to drive product development, enhance our sales,
marketing and professional services capabilities, and expand our footprint in
the U.S. marketplace. There is strong momentum building in the healthcare
market for EMR technology; with our industry reputation and proprietary
enterprise platform technology, we are well positioned to capture a
significant share of this opportunity."

Q2 Fiscal 2007 Financial Review
Revenue for Q2 2007 was $3.5 million, a 17% increase over revenue of $3.0
million for the previous quarter, which resulted primarily from a higher level
of software license sales generated in Q2 2007. Revenue for Q2 2007 increased
199% from $1.2 million generated in Q2 2006. This increase was due primarily
to the recently completed acquisitions of IHPS and HealtheNet.
Nightingale's gross profit margin was 72%, compared to gross profit
margin of 58% in Q1 2007. The margin improvement for the quarter was due to
Nightingale's success in increasing its efficiency of service delivery, the
reduction of costs related to the operations of recently acquired HealtheNet
and IHPS, as well as the benefits the Company realized throughout the quarter
from higher software license sales, which inherently carry higher gross profit
margins. Gross profit margin in Q2 2006 was 91%. The year-over-year decrease
in gross profit margin was a result of the revenue mix in the newly acquired
businesses that generates a higher percentage of sales from lower margin
service revenue.
During the quarter, the Company incurred expenses of $3.6 million, or
103% of revenue, a 12% decrease from $4.1 million, or 136% of revenue in Q1
2007. These cost savings were primarily driven by the elimination of one-time
expenses the Company incurred in Q1 2007 as a result of the interim debt
financing for the two acquisitions. Expenses for Q2 2006 were $1.3 million, or
115% of revenue.
Net loss for the three months ended September 30, 2006, was $1.1 million,
$0.03 per share or 31% of revenue, compared to a net loss of $2.3 million,
$0.07 per share or 78% of revenue in Q1 2007. Net loss for Q2 2006 was $0.28
million, $0.01 per share or 24% of revenue.

Six Month Financial Review
Revenue for the six month period ended September 30, 2006, was $6.5
million, up 197% from the same period last year.
Gross profit margin for the six months ended September 30, 2006 was 66%,
compared to a gross profit margin of 89% generated over the same period in
fiscal 2006. The lower margin for the first half of fiscal 2007 was primarily
a result of new lower margin sales in Q1 2007 generated by HealtheNet and
IHPS, which were acquired during the first quarter this year.
The total expenses Nightingale incurred for the six months ended
September 30, 2006, were $7.7 million, or 118% of revenue, compared to $2.4
million, or 108% of revenue, for the same period last year.
For the six-month period ended September 30, 2006, net loss was $3.4
million compared to $0.43 million for the same period in the previous year.
To view the full set of financial statements and MD&A for Nightingale,
visit http://www.nightingale.md or www.sedar.com

About Nightingale
Nightingale Informatix Corporation is one of North America's fastest
growing healthcare application service providers (ASP) for outpatient clinics.
Nightingale's Internet-based Electronic Health Record (EHR), Electronic
Medical Record (EMR) and practice management solutions are designed to help
physicians, clinics, hospitals and other healthcare organizations more
efficiently manage their operations and patient records.
Nightingale's products and services offer physicians in United States and
Canada leading-edge functionality for clinical documentation, patient
scheduling, resource scheduling, billing, transcription, end-to-end coding and
claims processing, data management, work flow tools, laboratory interfaces,
documentation management and patient portals, along with other real-time
services. The company's proprietary offerings of software include
myNightingale, Entity and Physician WorkStation, providing physicians with a
fully integrated, simple-to-use system that automates daily tasks and creates
a single, accessible source of patient data.

Forward Looking Statement
This press release contains "forward-looking statements" within the
meaning of applicable Canadian securities legislation. Generally,
forward-looking statements can be identified by the use of forward-looking
terminology such as "plans", "expects" or "does not expect", "is expected",
"budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or
"does not anticipate", or "believes", or variations of such words and phrases
or state that certain actions, events or results "may" ,"could", "would",
"might" or "will be taken", "occur" or "be achieved". Forward-looking
statements are subject to known and unknown risks, uncertainties and other
factors that may cause the actual results, level of activity, performance or
achievements of Nightingale to be materially different from those expressed or
implied by such forward-looking statements, including but not limited to:
risks related to the speculative nature of the medical software industry,
which is affected by numerous factors beyond Nightingale's control; the
ability of Nightingale to successfully integrate its acquisitions and any
liabilities arising as a result of such acquisitions; the existence of present
and possible future government regulation; the significant and increasing
competition that exists in the medical software industry; the early stage of
Nightingale's business; and therefore it is subject to the risks associated
with early stage companies, including uncertainty of revenues, markets and
profitability and the need to raise additional funding.
Although Nightingale has attempted to identify important factors that
could cause actual results to differ materially from those contained in
forward-looking statements, there may be other factors that cause results not
to be as anticipated, estimated or intended. There can be no assurance that
such statements will prove to be accurate, as actual results and future events
could differ materially from those anticipated in such statements.
Accordingly, readers should not place undue reliance on forward-looking
statements. Nightingale does not undertake to update any forward-looking
statements that are incorporated by reference herein, except in accordance
with applicable securities laws. Further information on Nightingale Informatix
Corporation is available at www.sedar.com

The TSX Venture Exchange Inc. has not reviewed and does not accept
responsibility for the adequacy or accuracy of this release.